Apellis Pharmaceuticals
APLS
APLS
260 hedge funds and large institutions have $4.04B invested in Apellis Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 98 increasing their positions, 71 reducing their positions, and 62 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
0% more first-time investments, than exits
New positions opened: 62 | Existing positions closed: 62
1% less funds holding
Funds holding: 263 → 260 (-3)
Holders
260
Holding in Top 10
6
Calls
$104M
Puts
$33.5M
Top Buyers
| 1 | +$188M | |
| 2 | +$68.3M | |
| 3 | +$41.7M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$41.4M |
| 5 |
CWM
CIBC World Markets
New York
|
+$38.7M |
Top Sellers
| 1 | -$113M | |
| 2 | -$104M | |
| 3 | -$88.3M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$63.6M |
| 5 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$39.1M |